| Mar'18 | Mar'17 | Mar'16 | Mar'15 | Mar'14 | Mar'13 | Mar'12 |
|---|---|---|---|---|---|---|
Operating activities | ||||||
Income from operations | ||||||
57,013 | 62,638 | 70,251 | 63,149 | 51,230 | 37,537 | 36,108 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Depreciation and amortization | ||||||
42,673 | 34,847 | 23,814 | 16,834 | 12,944 | 8,981 | - |
Deferred tax benefit (Note 15) | ||||||
-4,140 | -3,395 | -902 | -1,167 | -1,540 | - | - |
Depreciation | ||||||
- | - | - | - | - | - | 5,337 |
Amortization | ||||||
- | - | - | - | - | - | 2,405 |
Deferred tax expense (benefit) (Note 12) | ||||||
- | - | - | - | - | 152 | 599 |
Income from derivative financial instruments (Note 10) | ||||||
-1,791 | 1,314 | 261 | 412 | 615 | - | - |
Loss on foreign exchange (gain)/loss | ||||||
2,767 | -2,604 | -381 | -8,867 | -961 | -66 | -1,263 |
Provision for doubtful accounts (Note 2) | ||||||
941 | 380 | 311 | 805 | 386 | 190 | -1,861 |
Gain from revaluation of contingent liability (Note 9) | ||||||
-13,340 | -12,021 | -3,680 | 1,166 | 922 | - | - |
Unwinding of discount for contingent liability | ||||||
-1,215 | -1,990 | -1,169 | - | - | - | - |
Share-based compensation (Note 18) | ||||||
28,968 | 28,984 | 17,745 | 5,783 | 1,418 | 5,460 | 2,246 |
Impairment loss | ||||||
8,241 | 5,287 | 0 | 0 | - | - | - |
Other | ||||||
630 | 0 | 0 | - | - | - | - |
Other | ||||||
- | - | - | - | - | 13 | 101 |
Changes in operating assets and liabilities: | ||||||
Trade accounts receivable and unbilled revenue | ||||||
47,449 | -145 | 10,261 | 32,450 | 26,155 | 18,305 | - |
Trade accounts receivable | ||||||
- | - | - | - | - | - | 24,246 |
Work-in-progress | ||||||
928 | 1,210 | 146 | -3,271 | 1,242 | -419 | 2,599 |
Due to and from related parties | ||||||
-634 | 1,001 | -1,084 | 575 | 5,590 | -4,636 | -174 |
Accounts payable and accrued liabilities | ||||||
2,634 | 8,879 | 4,942 | -5,562 | - | - | - |
Accounts payable | ||||||
- | - | - | - | -1,281 | 989 | 4,309 |
Advances received | ||||||
- | - | - | - | - | 1,185 | 162 |
Accrued liabilities | ||||||
- | - | - | - | 2,768 | 1,435 | 530 |
Deferred revenue | ||||||
282 | -1,761 | -4,222 | 6,468 | 127 | - | - |
Changes in other assets and liabilities | ||||||
123 | 5,027 | -7,332 | -8,951 | -5,143 | -1,788 | -2,539 |
Net cash provided by operating activities | ||||||
75,007 | 122,027 | 105,389 | 76,278 | 50,656 | 35,248 | 26,517 |
Investing activities | ||||||
Purchases of property and equipment | ||||||
20,585 | 19,614 | 24,171 | 14,232 | 13,780 | 9,032 | 8,373 |
Purchases of intangible assets | ||||||
4,593 | 4,182 | 5,069 | 3,868 | 6,034 | 2,033 | 834 |
Proceeds from disposal of property and equipment | ||||||
0 | 0 | 40 | 77 | 301 | 352 | 720 |
Acquisitions, net of cash acquired (Note 2 and 9) | ||||||
34,155 | 77,672 | 3,525 | 24,257 | - | 1,605 | 1,510 |
Restricted cash | ||||||
-4,125 | 5,000 | 0 | - | - | - | - |
Loans repaid from related parties | ||||||
- | - | - | - | 380 | -3,800 | - |
Sale of Luxoft Consulting | ||||||
- | - | - | - | - | - | 283 |
Net cash used in investing activities | ||||||
-55,208 | -106,468 | -32,725 | -42,280 | -19,133 | -16,118 | -9,714 |
Financing activities | ||||||
Net repayment of short-term borrowings | ||||||
-785 | -5,897 | -880 | -18,594 | 3,687 | - | - |
Proceeds from short-term borrowings | ||||||
- | - | - | - | - | 22,022 | 10,156 |
Repayment of short-term borrowings | ||||||
- | - | - | - | - | 15,586 | 12,399 |
Acquisition of business, deferred consideration (Note 2 and 9) | ||||||
19,258 | 4,577 | 6,126 | 2,747 | 2,376 | - | - |
Repurchases of common stock | ||||||
5,547 | 3,611 | 1,774 | - | - | - | - |
Repayment of capital lease obligations | ||||||
163 | 133 | 124 | 38 | 83 | 485 | 531 |
Repayment of loans from related parties | ||||||
- | - | - | - | - | 5,547 | 11,835 |
Dividend paid | ||||||
- | - | - | 18 | 30,587 | 21,915 | 4,006 |
Proceeds from issue of shares pursuant to IPO | ||||||
- | - | - | - | 32,348 | - | - |
Repayment of IPO costs | ||||||
- | - | - | - | 1,312 | - | - |
Overdraft facilities, net | ||||||
- | - | - | -598 | -84 | 413 | 421 |
Net cash used in financing activities | ||||||
-25,753 | -14,218 | -8,904 | -21,995 | 1,593 | -21,098 | -18,194 |
Effect of exchange rate changes on cash and cash equivalents | ||||||
753 | -328 | -808 | -3,913 | -112 | -379 | -370 |
Net increase/(decrease) in cash and cash equivalents | ||||||
-5,201 | 1,013 | 62,952 | - | - | - | - |
Net increase in cash and cash equivalents | ||||||
- | - | - | 8,090 | 33,004 | -2,347 | -1,761 |
Supplemental disclosure of cash flow information | ||||||
Income tax paid | ||||||
13,862 | 12,861 | 12,942 | 3,013 | 3,375 | 3,337 | - |
Interest paid | ||||||
0 | 76 | 149 | 433 | 1,326 | 1,382 | - |
Government grants received in cash (Note 11) | ||||||
1,024 | 3,817 | 2,885 | - | - | - | - |